<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03436368</url>
  </required_header>
  <id_info>
    <org_study_id>CSARTR60</org_study_id>
    <nct_id>NCT03436368</nct_id>
  </id_info>
  <brief_title>Continuous Spinal Anesthesia in Renal Transplantation</brief_title>
  <official_title>Continuous Spinal Anesthesia for Renal Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nazmy Edward Seif</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Renal transplantation is now recognized as a treatment of choice for patients with end-stage
      renal disease. An adequate anesthetic technique should achieve hemodynamic stability and
      enhance perfusion of the transplanted kidney. The aim of this study is to assess the use &amp;
      effects of continuous spinal anesthesia for kidney transplantation recipients, compared with
      balanced general anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 20, 2018</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Using computer &amp; sealed envelope randomization, patients are assigned to receive either continuous spinal anesthesia [CSA group: n =30] or general anesthesia [GA group: n=30]</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Satisfaction Score</measure>
    <time_frame>24 hours</time_frame>
    <description>Patient satisfaction Score defines the degree of patient satisfaction with the anesthetic experience and is assessed after recovery. It is graded as excellent &quot;E&quot; (best score), fair &quot;F&quot; or poor &quot;P&quot; (worst score).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Score for pain &quot;VAS&quot;</measure>
    <time_frame>12 hours</time_frame>
    <description>Visual Analogue Score for pain measures the degree of pain experienced by the patient during the procedure. VAS is graded from 0-10 [where 0=no pain, 10= worst pain]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean ABP</measure>
    <time_frame>12 hours</time_frame>
    <description>Change in Mean Arterial Blood Pressure measured in mmHg</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Renal Failure Chronic</condition>
  <condition>Transplant;Failure,Kidney</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>CSA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous Spinal Anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>General Anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous spinal anesthesia</intervention_name>
    <description>Continuous spinal anesthesia will be performed for patients of the CSA group at the L3-L4 intervertebral space using Spinocath (B. Braun, Melsungen, Germany). After the cerebrospinal fluid is aspirated, 7.5 mg hyperbaric Bupivacaine 0.5% (1.5 ml) together with 25 micrograms Fentanyl (0.5 ml) will be injected intra-thecally. Supplemental injections will be given in aliquots of 5 mg hyperbaric Bupivacaine 0.5% (1 ml) if the sensory block is lower or reseeds, during surgery, below T6 dermatome.</description>
    <arm_group_label>CSA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia</intervention_name>
    <description>Anesthesia will be induced with intra-venous administration of Fentanyl (2 micrograms/kg), Ptopofol (1-2 mg/kg) and Atracurium (0.5 mg/kg). Maintenance will be achieved with 0.8-1.5% Isoflurane in an O2 / air mixture, an Atracurium infusion at 0.5 mg/kg/hr and a Fentanyl infusion at 1 micrograms/kg/hr.</description>
    <arm_group_label>GA group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA class III or IV

          -  End-stage renal disease

          -  Renal transplantation candidate patients

        Exclusion Criteria:

          -  Any condition contra-indicating regional anesthesia

          -  Coagulopathy

          -  Allergic to any of the drugs used during the procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nazmy E Seif, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Kasr Al-Ainy Hospital, Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nazmy E Seif, MD</last_name>
    <phone>01227400808</phone>
    <phone_ext>+2</phone_ext>
    <email>drnazmyseif@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kasr Al-Ainy Hospital, Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nazmy E Seif, MD</last_name>
      <phone>01227400808</phone>
      <phone_ext>+2</phone_ext>
      <email>drnazmyseif@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2018</study_first_submitted>
  <study_first_submitted_qc>February 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2018</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nazmy Edward Seif</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Continuous spinal anesthesia</keyword>
  <keyword>General anesthesia</keyword>
  <keyword>Renal transplantation</keyword>
  <keyword>Chronic renal failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

